G

Gan&Lee Pharmaceuticals

452 employees

Gan & Lee pharmaceutical is a Chinese high-tech biopharmaceutical company engaged in the R&D of insulin glargine and insulin lispro.

Investor insights

Funding rounds participated in

$78M sweet spot round size

Most of their 1 investments are in rounds between $78M and $78M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology

Pharmaceutical

Insulin

Biopharma

Diabetes

Medical Device

Biosimilars

Medical

Health Care

Date founded

1998

Investments made

U

Undisclosed raised $78M on November 15, 2021

Investors: CITIC Private Equity Funds Management, Sinopharm Capital 国药资本, 夏尔巴股权投资管理有限公司, SINOVAC科兴 and Gan&Lee Pharmaceuticals

Funding rounds raised

Total raised

$30M

from 5 investors over 5 rounds

G

Gan&Lee Pharmaceuticals raised undisclosed on January 1, 2015

Investors: Hillhouse Capital Management

G

Gan&Lee Pharmaceuticals raised undisclosed on February 1, 2012

Investors: Qiming Venture Partners

G

Gan&Lee Pharmaceuticals raised $30M on May 1, 2011

Investors: 北京腾业创业投资管理有限公司 and Qiming Venture Partners

G

Gan&Lee Pharmaceuticals raised $16M on December 1, 2009